Echocardiography Market Overview
The global echocardiography market is expected to expand at a CAGR of approximately 7% during the forecast period. Increasing prevalence of cardiovascular diseases, growing adoption of point-of-care (POC) cardiac imaging, expansion of the aging population, and rising preference for non-invasive diagnostic procedures are among the major factors supporting market growth. Technological advancements in ultrasound imaging, integration of artificial intelligence, and increasing awareness about early cardiovascular disease detection are further strengthening demand for echocardiography systems.
Echocardiography, commonly referred to as cardiac ultrasound or an echo, is a diagnostic imaging technique that uses high-frequency sound waves to generate real-time images of the heart. The procedure enables healthcare professionals to assess the structure and functioning of the heart, including its chambers, valves, blood flow, and overall cardiac performance. Echocardiography can also assist in identifying conditions such as blood clots, heart valve abnormalities, heart failure, and other cardiovascular disorders.
Major forms of echocardiography include transthoracic echocardiography, transesophageal echocardiography, and stress echocardiography. Transthoracic echocardiography remains one of the most commonly used approaches because it is non-invasive, relatively convenient, and does not expose patients to ionizing radiation.
The increasing global burden of cardiovascular disorders is creating sustained demand for cardiac imaging technologies. At the same time, healthcare providers are increasingly emphasizing early diagnosis and continuous monitoring of patients at risk of cardiovascular complications. These developments are expected to create favorable conditions for the echocardiography market over the coming years.
The COVID-19 pandemic temporarily disrupted market growth. Restrictions on movement, reduced hospital visits, postponement of non-emergency procedures, and the prioritization of COVID-19 cases led to lower volumes of cardiovascular diagnostic examinations. The global echocardiography market declined by approximately 8.3% in 2020 compared with the previous year.
Reduced utilization of diagnostic imaging systems also affected the revenues of manufacturers. For example, FUJIFILM Holdings Corporation reported revenue of approximately USD 19,966.3 million in 2020, representing a decline of 5.3% from 2019. The reduction was influenced by weaker demand in imaging solutions, although the company’s medical systems business recorded growth.
The market subsequently recovered in 2021 as restrictions were gradually lifted, vaccination programs expanded, healthcare facilities resumed routine services, and demand for cardiovascular diagnosis increased.
Key Request a free sample copy or view report summary: https://meditechinsights.com/echocardiography-market/request-sample/
Echocardiography Market Trends
Integration of Artificial Intelligence and Advanced Technologies
The integration of artificial intelligence into echocardiography is emerging as a major technological trend. AI-enabled systems can assist physicians in image analysis, automated measurements, disease detection, and workflow optimization. These capabilities can reduce the time required for certain examinations while improving consistency and reproducibility.
Manufacturers are increasingly incorporating advanced software into echocardiography platforms to support clinicians in obtaining and interpreting cardiac images. AI-based applications can also help standardize measurements and potentially reduce variations associated with manual analysis.
For instance, in December 2021, Koninklijke Philips introduced an AI-based automated measurement application for its EPIQ CVx and Affiniti CVx ultrasound systems. The technology was designed to provide faster and more consistent measurements compared with manual methods.
The development of three-dimensional imaging and virtual reality technologies is also expanding the capabilities of cardiac ultrasound. Three-dimensional visualization can provide physicians with a more comprehensive view of cardiac structures and may assist in treatment planning and procedural preparation.
In November 2020, Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd. announced an expanded categorization of the LVivo Cardiac ultrasound AI Toolbox on the Exa Cardio PACS platform, highlighting the increasing collaboration between imaging companies and AI developers.
The growing availability of pocket-sized and handheld ultrasound devices represents another important development. Portable systems can bring cardiac imaging closer to the patient and support diagnosis in emergency departments, intensive care units, outpatient settings, and other point-of-care environments.
Expansion of Point-of-Care Echocardiography
Point-of-care ultrasound is becoming increasingly important because it enables clinicians to conduct cardiac assessments directly at the patient’s location. Compact and portable echocardiography systems can be used in emergency care, critical care, ambulances, outpatient facilities, and other settings where conventional imaging equipment may not be readily available.
The growing emphasis on rapid diagnosis is encouraging healthcare providers to adopt portable cardiac ultrasound technologies. Improvements in image quality, battery life, connectivity, and software are also making handheld systems more practical for routine clinical applications.
Growth in Real-Time 3D Cardiac Imaging
Three-dimensional echocardiography is gaining attention because it can provide more detailed visualization of cardiac anatomy compared with conventional two-dimensional imaging. Real-time 3D imaging may support assessment of cardiac structures and assist clinicians during minimally invasive cardiovascular procedures.
In July 2021, Philips Healthcare introduced a real-time 3D intracardiac echocardiography catheter designed for minimally invasive cardiac procedures. Such developments demonstrate the increasing integration of advanced imaging technologies with interventional cardiology.
AI-Based Cardiovascular Disease Detection
Artificial intelligence is increasingly being applied to detect cardiovascular abnormalities and support clinical decision-making. AI algorithms can process large volumes of imaging data and assist healthcare professionals in identifying patterns associated with specific cardiac diseases.
The development of disease-specific algorithms is expected to create new opportunities for echocardiography manufacturers and healthcare technology companies. For example, in January 2024, Ultromics collaborated with Pfizer Inc. in relation to the U.S. FDA clearance of its EchoGo Amyloidosis algorithm, highlighting the growing application of AI in specialized cardiovascular diagnosis.
Echocardiography Market Growth Drivers
Rising Prevalence of Cardiovascular Diseases
The increasing burden of cardiovascular diseases is one of the strongest growth drivers for the echocardiography market. Conditions such as heart failure, cardiac arrhythmias, coronary artery disease, valvular heart disease, and pericardial disorders require accurate diagnosis and ongoing monitoring.
Lifestyle-related risk factors are also contributing to the growing cardiovascular disease burden. Physical inactivity, tobacco consumption, alcohol use, unhealthy diets, obesity, and high consumption of saturated fats and cholesterol can increase the risk of cardiovascular complications.
According to data from the U.S. Centers for Disease Control and Prevention, approximately 805,000 people in the U.S. experience a heart attack each year, including around 605,000 individuals experiencing their first heart attack.
The cardiovascular disease burden is also significant across Europe. More than half of deaths in the region are attributed to cardiovascular diseases, demonstrating the substantial need for effective cardiac diagnostic technologies.
The high incidence of cardiovascular disorders is therefore expected to sustain demand for echocardiography systems across hospitals, diagnostic centers, cardiology clinics, and other healthcare facilities.
Increasing Focus on Early Diagnosis and Preventive Healthcare
Growing awareness about the importance of cardiovascular screening is encouraging patients to seek earlier diagnosis and monitoring. Healthcare organizations and government agencies are implementing initiatives designed to reduce cardiovascular mortality and promote healthier lifestyles.
For example, in February 2024, the U.S. Department of Health and Human Services highlighted the Million Hearts initiative, jointly led by the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services, with the goal of reducing heart attacks and strokes by 2027.
Such programs are increasing awareness of cardiovascular risk factors and the importance of timely diagnosis. As preventive healthcare becomes more prominent, demand for accessible and non-invasive cardiac imaging technologies is expected to increase.
Advantages of Echocardiography Over Invasive Diagnostic Methods
The non-invasive nature of echocardiography is a significant factor supporting its adoption. Unlike cardiac catheterization and certain other diagnostic approaches, echocardiography does not require surgical access to blood vessels and does not rely on ionizing radiation.
Cardiac catheterization, while clinically valuable for specific applications, can be associated with complications such as bleeding, blood clots, arterial injury, and other procedural risks. Echocardiography offers clinicians a comparatively safer method for evaluating cardiac structure and function.
The technology can be used for diagnosing and monitoring a wide range of cardiac conditions. It is also useful for patients requiring repeated examinations, including individuals with heart failure.
Echocardiography can additionally be used to monitor cardiac function in cancer patients receiving treatments that may cause cardiotoxicity. The broad clinical utility of the technology therefore contributes to continued demand across different patient populations.
Growing Aging Population
Population aging is expected to contribute significantly to echocardiography market growth. Older adults have a higher risk of developing cardiovascular disorders and frequently require regular monitoring of cardiac function.
The increasing number of elderly patients is therefore expanding the potential demand for cardiac imaging services. Hospitals and diagnostic centers are investing in technologies capable of supporting the growing need for cardiovascular assessment, creating opportunities for echocardiography manufacturers.
Market Restraining Factors
High Cost of Advanced Echocardiography Systems
The relatively high acquisition cost of echocardiography equipment can limit adoption, particularly among smaller hospitals and healthcare facilities in developing economies. Advanced systems incorporating 3D imaging, AI capabilities, high-resolution visualization, and specialized cardiac applications typically require substantial investment.
An echocardiography system can cost approximately USD 20,000 at the lower end and reach USD 100,000 or more for sophisticated systems. The financial burden associated with equipment acquisition, maintenance, software upgrades, and staff training may restrict adoption in cost-sensitive markets.
Patients may also face significant procedure-related expenses depending on the type of examination, healthcare provider, insurance coverage, and geographic location. Data provided by Sesame, Inc. in August 2023 indicated that echocardiogram procedures could typically cost between approximately USD 1,000 and more than USD 3,000.
Shortage of Skilled Professionals
The effectiveness of echocardiography depends not only on the equipment but also on the expertise of sonographers, cardiologists, and other trained professionals. A shortage of skilled personnel can restrict the utilization of advanced systems and affect access to high-quality cardiac imaging.
Training requirements can be particularly challenging for emerging markets where access to specialized cardiovascular professionals remains limited.
Limitations of Handheld Devices
Portable and handheld cardiac ultrasound systems offer advantages in terms of mobility and accessibility but can have certain limitations compared with full-sized systems. Smaller screens, lower image resolution, limited imaging frequencies, and reduced image optimization can affect their use in complex diagnostic situations.
Some handheld systems may also have more limited imaging capabilities, including restrictions associated with two-dimensional visualization. Consequently, portable systems are likely to complement rather than completely replace comprehensive echocardiography platforms.
Regional Market Outlook
North America
North America is expected to remain a leading region in the global echocardiography market. High adoption of advanced medical technologies, strong healthcare infrastructure, significant cardiovascular disease burden, and favorable reimbursement conditions support regional demand.
The presence of leading medical imaging companies and continuous investment in AI-enabled healthcare technologies further strengthens the region’s market position.
Europe
Europe represents another significant market for echocardiography systems. The region benefits from established healthcare infrastructure and increasing efforts to improve cardiovascular disease prevention and diagnosis.
Collaborations between manufacturers, technology companies, and research organizations are supporting the development of AI-based imaging applications and advanced cardiac diagnostic technologies. Strategic partnerships, acquisitions, and research investments are expected to contribute to regional growth.
Asia-Pacific
Asia-Pacific is expected to provide considerable growth opportunities during the forecast period. Rising healthcare expenditure, increasing awareness of cardiovascular diseases, improving diagnostic infrastructure, and a growing elderly population are supporting demand.
The expansion of hospitals and diagnostic centers, combined with increasing adoption of portable and point-of-care ultrasound systems, is expected to improve access to echocardiography across emerging economies.
Competitive Landscape
The global echocardiography market includes established medical device manufacturers, diagnostic technology companies, and emerging AI-focused healthcare organizations. Competition is centered on technological innovation, image quality, portability, AI integration, workflow efficiency, and the development of specialized cardiac imaging solutions.
Companies are increasingly pursuing product launches, strategic partnerships, collaborations, research investments, acquisitions, and technology development to strengthen their market positions. The integration of AI and advanced imaging capabilities is expected to remain a major area of competitive differentiation.
Key players include:
- GE HealthCare
- Koninklijke Philips N.V.
- Siemens Healthineers
- Canon Medical Systems Corporation
- Esaote S.p.A.
- Samsung Electronics Co., Ltd.
- FUJIFILM Holdings Corporation
- Hitachi Medical Corporation
- Bay Labs
- Bracco Imaging S.p.A.
- ContextVision AB
- Digirad Corporation
- TELEMED Medical Systems
Future Outlook
The global echocardiography market is expected to maintain steady growth as cardiovascular disease prevalence increases and healthcare providers place greater emphasis on early diagnosis, preventive care, and continuous patient monitoring. The combination of non-invasive imaging, expanding point-of-care applications, and technological innovation is expected to broaden the clinical use of echocardiography.
AI is likely to remain one of the most transformative technologies in the market. Automated measurements, image interpretation, disease-specific algorithms, workflow optimization, and decision-support capabilities could improve the efficiency and consistency of cardiac ultrasound examinations.
At the same time, manufacturers are expected to focus on developing compact, affordable, and high-performance systems to expand access to cardiac imaging. Growth in emerging markets will depend on improvements in healthcare infrastructure, professional training, reimbursement, and affordability.
Overall, the market is transitioning toward intelligent, portable, connected, and increasingly automated cardiac imaging solutions. Companies that successfully combine advanced imaging performance with ease of use, cost efficiency, AI capabilities, and clinical reliability are likely to capture significant opportunities in the evolving echocardiography market.
Key Request a free sample copy or view report summary: https://meditechinsights.com/echocardiography-market/request-sample/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
